This deal fundamentally revalues Inovio. One of the largest pharmaceutical companies in the world feels that Inovio's DNA vaccine technology, and electroporation technology is worth investing over 400 million dollars in.
Roche feels that INO-5150 and INO-1800 are worth 422 million, leaving us with the question of what is the rest of the pipeline worth? There are 10 other products in Inovio's pipeline.Roche feels that INO-5150 and INO-1800 are worth 422 million, leaving us with the question of what is the rest of the pipeline worth? There are 10 other products in Inovio's pipeline.
Sentiment: Strong Buy
Well, I think the real value of the Roche deal has been to validate our runup from .60 to 2.44. That's pretty good start. We'll get more value when the next data or deal is announced. Patience will be rewarded, and it won't be long, by EOY max.
"When you buy Inovio today, much of what you are buying is Dr. Joseph Kim and Dr. David Weiner. These two men head up the technology that Inovio is developing. All investors interested in Inovio should do a good bit of research of both men. Both have long histories and are at the top of their fields."
Thank you for appreciating these guys, I can only imagine how wonderful they must feel with their work finally coming to fruition.
INO is worth $2.50 until further notice. Don't get ur panties bunched up just yet. The stock moved from .50 to $2.50 in anticaopation of the deal, now the fanfair is over and they will have to justify the 500 mil mkt cap.